WAS and neoplasm: In benign T and B cells, WASp is a tumor-suppressor protein, however it acts as a tumor activator in malignant lymphocytes, since the lack of WASp leads to an imbalance of CDC42/MAPK and NF-κB/AP-1 signaling pathways, which is important for the development of cancer (323).